European Pharmaceutical Review

MAY 7, 2024

percent compound annual growth rate (CAGR) between 2024 to 2029. billion by 2029. The report found that additionally, the sector is seeing growth due to factors such as emerging economies experiencing rapid urbanisation and better infrastructure within healthcare. by 2029 appeared first on European Pharmaceutical Review.

Food and Drug Administration 69

Food and Drug Administration Marketing Government Food 69

Clarivate

JANUARY 8, 2024

Clarivate data indicates a 90% probability that datopotamab deruxtecan will win marketing authorization in the United States, and projects 2029 sales of $2.7 billion in 2029 for CASGEVY alone. FDA accelerated approval in August, Clarivate projects the drug will see $850 million in sales by 2029. billion in 2029 revenues.

Marketing 59

Marketing Patients Healthcare Healthcare 59

World of DTC Marketing

AUGUST 7, 2022

One in three GoFundMe campaigns is now for healthcare-related costs, and it’s getting worse. The passage of the Inflation Control bill is an excellent first step in limiting high drug costs, but our healthcare system is still built for profit at the expense of patients. According to a 2021 study , 1.1 Schumer (D-N.Y.)

Insurance 263

Insurance Doctors Government Physicians 263

Pharmaceutical Technology

APRIL 28, 2023

In 2022, US sales of Ozempic contributed to 65% of global sales; this is expected to continue, with the US market forecast to continue capturing the majority of sales, generating $71bn between 2023–2029. It is forecast that Ozempic will sustain its sales growth over the next five years, with an expected annual sales figure of $17bn in 2029.

Sales 52

Sales Marketing Medical Patients 52

Medico Reach

OCTOBER 17, 2022

What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. billion by 2029. Healthcare executives are also looking into AR spinal surgical systems.

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

PM360

APRIL 7, 2023

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

Medico Reach

OCTOBER 17, 2022

What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. billion by 2029. Healthcare executives are also looking into AR spinal surgical systems.

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52